Pan-cancer analysis based on the TCGA database (https://portal.gdc.cancer.gov/) showed that SLC16A1-AS1 exhibits a high expression pattern in multiple gastrointestinal carcinomas including LIHC, colon adenocarcinoma (COAD), cholangiocarcinoma (CHOL), and esophageal carcinoma (ESCA) (Supplementary Fig. S2K). The gene discussed is SLC16A1; the disease is colon adenocarcinoma.